Remed Co.Ltd Capital Reinvestment Ratio
Remed Co.Ltd capital reinvestment ratio. Remed Co.Ltd (302550) has a Capital Reinvestment Ratio of 1.14x as of June 2026, meaning it reinvests 1% of its operating cash flow (₩1.74 Billion) in capital expenditures (₩1.99 Billion). Check 302550 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Remed Co.Ltd (2017–2025)
Capital reinvestment ratio of Remed Co.Ltd from 2017 to 2025. This chart tracks Remed Co.Ltd's Capital Reinvestment Ratio across 7 annual periods. Also explore 302550 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Remed Co.Ltd Capital Reinvestment Ratio by Year (2017–2025)
Remed Co.Ltd capital reinvestment ratio by year from 2017 to 2025. For the full cash flow conversion analysis, see Remed Co.Ltd cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.36x | ₩2.40 Billion | ₩868.76 Million | ▼ -25.9% |
| 2024 | 0.49x | ₩1.24 Billion | ₩608.80 Million | ▲ +91.5% |
| 2023 | 0.26x | ₩3.50 Billion | ₩893.97 Million | ▼ -72.1% |
| 2022 | 0.92x | ₩5.21 Billion | ₩4.77 Billion | ▲ +248.9% |
| 2020 | 0.26x | ₩2.59 Billion | ₩679.62 Million | ▼ -57.9% |
| 2019 | 0.62x | ₩3.22 Billion | ₩2.01 Billion | ▼ -94.6% |
| 2017 | 11.52x | ₩66.75 Million | ₩768.89 Million | — |